Opiant Pharmaceuticals Stock Price, News & Analysis
Company Description
Opiant Pharmaceuticals (NASDAQ: OPNT) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $108.8M.
OPNT stock has declined 28.8% over the past year.
This page provides a comprehensive overview of OPNT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Opiant Pharmaceuticals (OPNT) stock. Over the past 12 months, the stock has lost 28.8%. At a market capitalization of $108.8M, OPNT is classified as a micro-cap stock with approximately 5.3M shares outstanding.
Latest News
Opiant Pharmaceuticals has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, clinical trial, fda approval, earnings, conferences. View all OPNT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
OPNT Company Profile & Sector Positioning
Opiant Pharmaceuticals (OPNT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing OPNT often look at related companies in the same sector, including Fortress Biotech Inc (FBIO), Zentalis Pharmaceuticals, Inc. (ZNTL), Adagene Inc. (ADAG), Spero Therapeuti (SPRO), and Vistagen Therapeutics Inc (VTGN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OPNT's relative position within its industry.